Scale-up of national antiretroviral therapy programs: Progress and challenges in the Asia Pacific region

AIDS

Volumn 24, Issue SUPPL. 3, 2010, Pages

  Srikantiah, Padmini ^a   Ghidinelli, Massimo ^b   Bachani, Damodar ^c   Chasombat, Sanchai ^d   Daoni, Esorom ^e   Mustikawati, Dyah E ^f   Nhan, Do T ^g   Pathak, Laxmi R ^h   San, Khin O ⁱ   Vun, Mean C ^j   Zhang, Fujie ^k   Lo, Ying Ru ^b   Narain, Jai P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c GOVERNMENT OF INDIA   (India)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

^e National Department of Health   (Papua New Guinea)

^f MINISTRY OF HEALTH   (Indonesia)

^g Vietnam Administration for HIV/AIDS Control   (Viet Nam)

^h National Centre for AIDS and STD Control   (Nepal)

ⁱ DEPARTMENT OF HEALTH   (Myanmar)

^j National Clinic for Dermatology and STD Unit   (Cambodia)

^k CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

more..

Author keywords

Antiretroviral therapy; Asia Pacific; HIV; Outcomes; Scale up; Treatment

Indexed keywords

EFAVIRENZ; ISONIAZID; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ARTICLE; CLINICAL PRACTICE; FOLLOW UP; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MIXED INFECTION; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCALE UP; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; ASIA; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; NATIONAL HEALTH PROGRAMS; UNITED NATIONS;

EID: 78650465686     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000390091.45435.ea     Document Type: Article

References (71)

1. UNAIDS. AIDS epidemic update, December 2009. Geneva, Switzerland; 2009.
2. World Health Organization Regional Office for South-East Asia. HIV/AIDS in the south-east Asia region. New Delhi, India: World Health Organization Regional Office for South-East Asia; 2009.
3. World Health Organization Regional Office for South-East Asia. Scaling-up towards universal access to HIV prevention, treatment, and care. New Delhi, India: WHO Regional Office for South-East Asia; 2006.
4. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367:817-824.
5. Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K, et al. National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr 2009; 50:506-512.
6. Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, et al. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. AIDS 2007; 21:351-359.
7. Zhang F, Dou Z, Yu L, Xu J, Jiao JH, Wang N, et al. The effect of highly active antiretroviral therapy on mortality among HIV infected former plasma donors in China. Clin Infect Dis 2008; 47:825-833.
8. Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med 2009; 151:241-251; W-52.
9. Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, et al. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med 2007; 8:8-16.
10. World Health Organization. Toward Universal Access: Scaling up Priority Interventions in the Health Sector, 2009 Progress Report. Geneva; 2009.
11. WHO UNICEF UNAIDS. Joint reporting tool on the health sector response to HIV/AIDS 2009. Geneva, Switzerland; 2009 [cited July 2009]. http://www.who.int/ hiv/data/tools/en/index.html.
12. WHO/UNICEF/UNAIDS. Joint reporting tool on the health sector response to HIV/AIDS 2010. Geneva, Switzerland; 2010 [cited 19 July 2010]. http://www.who.int/hiv/data/tool2010/en/index.html.
13. Ministry of Health and Population Nepal. UNGASS Country Progress Report Nepal 2010; 2010 [cited 19 July 2010]. http://www.unaids.org/en/KnowledgeCentre/ HIVData/CountryProgress/2010CountryProgressAllCountries.asp.
14. Ministry of Health of the People's Republic of China. China 2010 UNGASS Country Progress Report. Beijing, China; 2010 [cited 19 July 2010]. http://www.unaids.org/en/KnowledgeCentre/HIVData/CountryProgress/ 2010CountryProgressAllCountries.asp.
15. NACO. Country Progress Report: UNGASS, India 2010. New Delhi, India; 2010 [cited 19 July 2010]. http://www.unaids.org/en/KnowledgeCentre/HIVData/ CountryProgress/2010Country ProgressAllCountries.asp.
16. National AIDS Commission Republic of Indonesia. Country Report on the Follow up to the Declaration of Commitment on HIV/AIDS (UNGASS), 2009-2009 Reporting Period. Jakarta, Indonesia; 2010 [cited 19 July 2010]. http://www.unaids.org/en/KnowledgeCentre/HIVData/CountryProgress/ 2010CountryProgressAllCountries.asp.
17. National AIDS Prevention and Alleviation Committee Thailand. UNGASS Country Progress Report Thailand, Reporting Period 2008-2009; 2010 [cited 19 July 2010]. http://www.unaids.org/en/KnowledgeCentre/HIVData/CountryProgress/ 2010Country-ProgressAllCountries.asp.
18. National AIDS Program Union of Myanmar. UNGASS Country Progress Report Myanmar. Nay Pyi Taw, Myanmar; 2010 [cited 19 July 2010]. http://www.unaids.org/ en/KnowledgeCentre/HIVData/CountryProgress/2010CountryProgressAllCountries.asp.
19. Papua New Guinea National AIDS Council Secretariat. UNGASS 2010 Country Progress Report. Papua New Guinea; 2010 [cited 19 July 2010]. http://www.unaids.org/en/KnowledgeCentre/HIVData/CountryProgress/ 2010CountryProgressAllCountries.asp.
20. The National AIDS Authority Kingdom of Cambodia. Cambodia Country Progress Report: Monitoring the Progress Towards the Implementation of the Declaration of Commitment on HIV and AIDS. Phnom Penh, Cambodia; 2010 [cited 19 July 2010]. http://www.unaids.org/en/KnowledgeCentre/HIVData/CountryProgress/ 2010CountryProgressAllCountries.asp.
21. The Socialist Republic of Vietnam. Declaration of Commitment on HIV and AIDS adopted at the 26th United Nations General Assembly Special Session in June 2001 (UNGASS): Vietnam Country Progress Report; 2010 [cited 19 July 2010]. http://www.unaids.org/en/KnowledgeCentre/HIVData/CountryProgress/ 2010CountryProgressAllCountries.asp.
22. World Health Organization. Toward universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva; 2008.
23. China Center for Disease Control and Prevention. China Free ART Manual; 2008.
24. Sungkanuparph S, Techasathit W, Utaipiboon J, Chasombat S, Bhakeecheep S, Leechawengwongs M, et al. Thai National Guidelines for Antiretroviral Therapy in HIV-1 Infected Adults and Adolescents 2010. Asian Biomed 2010; 4:515-528.
25. Ministry of Health, Republic of Indonesia. National Guidelines on Antiretroviral Therapy and HIV Clinical management for Adolescence and Adults. Second Edition, 2008. Jakarta, Indonesia, 2008.
26. Ministry of Health and Family Welfare Government of India. Antiretroviral Therapy Guidelines for HIV-Infected Adults and Adolescents Including Postexposure Prophylaxis. New Delhi, India: National AIDS Control Organisation; 2007.
27. National AIDS-STD Control Programme, Department of Health. Guidelines for the Clinical Management of HIV Infection in Adults and Adolescents. Ministry of Health Myanmar; 2007.
28. National Center for AIDS and STD Control Nepal. National Guidelines on ARV Therapy; 2005.
29. National Center for HIV/AIDS Dermatology and STDS. National Guidelines for the Use of Antiretroviral Therapy in Adults and Adolescents. Kingdom of Cambodia Ministry of Health; 2007.
30. National Department of Health Papua New Guinea. Guidelines for HIV Care and Treatment in Papua New Guinea; 2009.
31. Vietnam Administration for HIV/AIDS Control. Antiretroviral Therapy Guidelines for Adults and Adolescents; 2006.
32. UNAIDS. Papua New Guinea releases new HIV prevalence estimates. Aug 26, 2010. Accessed 6 September, 2010. Available from: http://www.unaids.org/en/ KnowledgeCentre/Resources/FeatureStories/archive/2010/20100826-FS-PNG.asp.
33. WHO. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach [2010 revision]. Geneva, Switzerland: WHO; 2010 [cited 19 July 2010]. http://whqlibdoc.who.int/ publications/2010/9789241599764-eng.pdf.
34. Shah B, Walshe L, Saple DG, Mehta SH, Ramnani JP, Kharkar RD, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis 2007; 44: 1235-1244.
35. Zhang F, Haberer JE, Zhao Y, Dou Z, Zhao H, He Y, et al. Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes. J Acquir Immune Defic Syndr 2007; 46: 594-598.
36. Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV, Losina E, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and metaanalysis. Clin Infect Dis 2009; 49:1915-1927.
37. Janssens B, Raleigh B, Soeung S, Akao K, Te V, Gupta J, et al. Effectiveness of highly active antiretroviral therapy in HIVpositive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics 2007; 120:e1134-e1140.
38. Jadhav M, Pensi T, Chan P, Purohit V, Paithankar P, Rewari BB, et al. Scaling up access to paediatric ART in India [abstract THPDB108]. XVII International AIDS Conference; Mexico City; 2008.
39. National Centre for HIV/AIDS Dermatology and STDs. Guidance on change in the biological criterion for starting antiretroviral therapy by increasing CD4 threshold from 250 cells per cubic milliliter to 350 cells per milliliter and antiretroviral therapy for TB-HIV patients. Phnom Penh; 2010 [cited 19 July 2010]. http://www.nchads.org/Guideline/guide1.pdf.
40. Crowley S, Rollins N, Shaffer N, Guerma T, Vitoria M, Lo YR. New WHO HIV Treatment and Prevention Guidelines. Lancet 2010; 375:874-875.
41. Rewari BB, Bachani D, Garg R, Deshpande A, Rajasekharan S, Emmanuel KV, et al. Two-year treatment outcomes of the firstline antiretroviral therapy programme in India. XVII International AIDS Conference; Mexico City; 2008.
42. Gnana Durai Pandian AG, Kandaswamy R, Nadol P, Chandrasekar S. Clinical and immunologic response to highly active antiretroviral therapy in paediatric patients: a retrospective cohort study at Government Hospital for Thoracic Medicine, India [abstract CDB102]. 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention; Cape Town, South Africa; 2009.
43. McConnell M, Yuktanont P, Siangphoe U, Pattarapayoon N, Kohreadnudom S, Lokekha R, et al. Survival rates following expansion of the national pediatric antiretroviral treatment program, Thailand, 2000-2005 [abstract MoAb101]. 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention; Cape Town, South Africa; 2009.
44. Ferradini L, Segeral O, Nouhin J, Leakhena S, Vara O, Dulioust A, et al. Efficacy of Kaletra-based second-line ART in Cambodia [abstract 36LB]. 14th Conference on Retroviruses and Opportunistic Infections; Los Angeles; 2007.
45. Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS 2007; 21 (Suppl 8):S143-S148.
46. Jordan MR, La H, Nguyen HD, Sheehan H, Lien TT, Duong DV, et al. Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam. Int J STD AIDS 2009; 20:418-422.
47. Ford N, Wilson D, Cawthorne P, Kumphitak A, Kasi-Sedapan S, Kaetkaew S, et al. Challenge and co-operation: civil society activism for access to HIV treatment in Thailand. Trop Med Int Health 2009; 14:258-266.
48. Joint United Nations Programme on HIV/AIDS. Report on the Global AIDS Epidemic, 2008. Geneva; 2008.
49. Ruxrungtham K, Brown T, Phanuphak P. HIV/AIDS in Asia. Lancet 2004; 364:69-82.
50. Zhang FJ, Pan J, Yu L, Wen Y, Zhao Y. Current progress of China's free ART program. Cell Res 2005; 15:877-882.
51. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005; 19:2141-2148.
52. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006; 367:1335-1342.
53. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296:782-793.
54. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22:1897-1908.
55. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004; 364:1428-1434.
56. Sharma M, Oppenheimer E, Saidel T, Loo V, Garg R. A situation update on HIV epidemics among people who inject drugs and national responses in south-east Asia region. AIDS 2009; 23:1405-1413.
57. Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res 2004; 120:277-289.
58. Varma JK, Nateniyom S, Akksilp S, Mankatittham W, Sirinak C, Sattayawuthipong W, et al. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis 2009; 9:42.
59. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 2008; 86:559-567.
60. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Nonadherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001; 15:1181-1183.
61. WHO. Monitoring of HIV drug resistance emerging during treatment and related programme factors in sentinel ART sites in resource-limited settings. Geneva: WHO; 2005.
62. Forster M, Bailey C, Brinkhof MW, Graber C, Boulle A, Spohr M, et al. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ 2008; 86: 939-947.
63. Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health 2008; 13:904-913.
64. Hosseinipour MC, van Oosterhout JJ, Weigel R, Phiri S, Kamwendo D, Parkin N, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS 2009; 23:1127-1134.
65. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Clin Infect Dis 2007; 44: 447-452.
66. Chasombat S, Lertpiriyasuwat C, Thanprasertsuk S, Suebsaeng L, Lo YR. The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand. Southeast Asian J Trop Med Public Health 2006; 37:704-715.
67. World Health Organization Regional Office for South-East Asia. Scaling up antiretroviral treatment: lessons learnt from Thailand. New Delhi, India: WHO Regional Office for South-East Asia; 2007.
68. Chan P, Karthikeyan K, Stephen JS, Ramesh N, Palicheralu B, Swaminathan S, et al. WHO Integrated Management of Adult and Adolescent Illness (IMAI) Package for HIV Care helps strengthen primary health systems in two high HIV burden districts of southern India [abstract WEPE0087]. XVII International AIDS Conference; Mexico City, Mexico; 2008.
69. Genberg BL, Hlavka Z, Konda KA, Maman S, Chariyalertsak S, Chingono A, et al. A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med 2009; 68:2279-2287.
70. Genberg BL, Kawichai S, Chingono A, Sendah M, Chariyalertsak S, Konda KA, et al. Assessing HIV/AIDS stigma and discrimination in developing countries. AIDS Behav 2008; 12: 772-780.
71. Ford N, Wilson D, Costa Chaves G, Lotrowska M, Kijtiwatchakul K. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand. AIDS 2007; 21 (Suppl 4):S21-S29.